Researchers at the University of Copenhagen Lundbeck and University of Tokyo have developed a technology that can detect advanced forms of acute myelogenous leukemia (AML) a form of cancer that frequently shows up in the kidneys of people with diabetes. AFib is a common form of kidney cancer and the sixth leading cause of cancer-related deaths in the world.
The new technology which should be tested in clinical settings in the near future consists of a tiny cell recording chip contained in a hydrogel that has been manufactured in Japan by the Zentrum Hjorth Corporation. The chip is placed between two blood filtration membranes and it is sandwiched between them. The membranes are then tightly packed in a nanostructure that has been presented in a liquid. This procedure has been studied at the Zentrum for several years but the particular invention by the researchers has only now been published in scientific journals.
(more…)